SELECT COUNTRY

VIEW ALL
AFRICA
AMERICAS
ASIA
EUROPE
OCEANIA

UNITED STATES: LATEST INTERVIEWS MORE INTERVIEWS

Donna LaVoie
FOUNDER AND CEO, LAVOIEHEALTHSCIENCE
"For biotechs, finding the balance between appealing to the public and institutional investors will be a challenge, much like trying to balance a recipe with the right mix of ingredients for the perfect dish."
United States
Pharma & Life Sciences
Debbie Hart
PRESIDENT AND CEO, BIONJ
"New Jersey is home to eight of the top 10 global biopharmaceutical companies, nine of the top 10 R&D firms, and over 5,600 life sciences establishments. The State accounted for 43% of all novel FDA approvals in the past two years."
United States
Pharma & Life Sciences
David Short
SR. MANAGER, BUSINESS DEVELOPMENT - US & CANADA, PROCOS SPA
"Procos is poised for transformative growth in 2025. Our R11 facility will significantly enhance our small-scale production capacity, enabling us to meet the growing demand for high-quality, specialized APIs in the US market."
United States
Pharma & Life Sciences
Eric Smith
MANAGING DIRECTOR, CEMENTATION AMERICAS
"Inflation has undoubtedly impacted mining costs across North America, especially in terms of labor and materials."
Mining
Canada
United States

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Peru Mining 2025 PDAC Pre-Release

Featuring insights from nearly 50 mining executives, the PDAC pre-release version of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting the country's window of opportunity with the energy transition and copper's critical role.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL